"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","23/43","481/2914",2.31332574044116e-08,5.10137455900436e-06,2.95280442174633e-06,"MAPK1/MEN1/SMAD2/MAPK14/SP1/CDK5/NR4A1/AKT1/CSNK2A1/MAPK3/SMAD3/SIRT1/NR0B2/MYB/ATF2/ZNF521/HDAC1/SMAD4/NR2C2AP/SRC/PPP2R5C/RARG/RARB",23
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","21/43","397/2914",2.36722717355191e-08,5.10137455900436e-06,2.95280442174633e-06,"STAT3/MAPK1/SMAD2/MAPK14/CEBPB/CDK5/NR2F2/AKT1/CSNK2A1/MAPK3/SMAD3/PAK1/MYB/SMAD4/HSP90AB1/GRB10/SRC/EPHA4/RARG/RARB/FLI1",21
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","23/43","499/2914",4.77169717857768e-08,6.85533827988993e-06,3.96804291692249e-06,"MAPK1/MEN1/SMAD2/MAPK14/SP1/CDK5/NR4A1/AKT1/CSNK2A1/MAPK3/SMAD3/SIRT1/NR0B2/MYB/ATF2/ZNF521/HDAC1/SMAD4/NR2C2AP/SRC/PPP2R5C/RARG/RARB",23
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","7/43","34/2914",3.67366654693484e-07,3.95837570432229e-05,2.291207820062e-05,"MAPK1/DUSP2/MAPK3/DUSP7/DUSP10/PPP2R5B/PPP2R5C",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","13/43","172/2914",5.19565341000519e-07,4.47865323942447e-05,2.59235759614996e-05,"MAPK1/NR4A1/AKT1/CSNK2A1/MAPK3/ATF2/HDAC1/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1/PHLPP2",13
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","6/43","24/2914",7.9610363999952e-07,5.71867781399655e-05,3.31011513473485e-05,"MEN1/SMAD2/SP1/SMAD3/HDAC1/SMAD4",6
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","11/43","136/2914",2.44053936427536e-06,0.000148544944279147,8.59815650119864e-05,"MAPK1/SP1/AKT1/MAPK3/MYB/ATF2/HDAC1/HSP90AB1/SRC/RARG/RARB",11
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","15/43","268/2914",2.75721474300041e-06,0.000148544944279147,8.59815650119864e-05,"STAT3/MAPK1/SMAD2/NR4A1/AKT1/MAPK3/SMAD3/HDAC1/SMAD4/AMER1/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1",15
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","13/43","201/2914",3.14578240562614e-06,0.000150648024091652,8.7198880717356e-05,"MAPK1/NR4A1/AKT1/CSNK2A1/MAPK3/ATF2/HDAC1/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1/PHLPP2",13
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/43","10/2914",8.10289420415451e-06,0.00031748612745369,0.000183768988170777,"MAPK1/MAPK14/MAPK3/ATF2",4
"R-HSA-74749","R-HSA-74749","Signal attenuation","4/43","10/2914",8.10289420415451e-06,0.00031748612745369,0.000183768988170777,"MAPK1/MAPK3/GRB10/IRS1",4
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","9/43","99/2914",9.04997686405025e-06,0.000325045002367138,0.000188144255857887,"MAPK1/AKT1/MAPK3/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1/PHLPP2",9
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","6/43","36/2914",1.00982586495542e-05,0.000334796113689065,0.000193788445339622,"MEN1/SMAD2/SP1/SMAD3/HDAC1/SMAD4",6
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","12/43","191/2914",1.12887320587202e-05,0.000347531679807742,0.000201160112625314,"MAPK1/AKT1/CSNK2A1/MAPK3/CSNK1D/HDAC1/HSP90AB1/PTK6/SRC/PPP2R5B/PPP2R5C/PPP1CB",12
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","5/43","23/2914",1.52439252811057e-05,0.000438008786410436,0.000253530546780494,"MAPK1/DUSP2/MAPK3/DUSP7/DUSP10",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","9/43","108/2914",1.85573717464695e-05,0.00048287170205436,0.000279498335295844,"MAPK1/SP1/AKT1/MAPK3/MYB/ATF2/HDAC1/HSP90AB1/SRC",9
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/43","24/2914",1.90459836077126e-05,0.00048287170205436,0.000279498335295844,"MAPK1/MAPK3/ZNF521/SMAD4/SRC",5
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","7/43","63/2914",2.75028443032423e-05,0.00065854032748319,0.00038117977192213,"MEN1/SMAD2/SP1/SMAD3/HDAC1/SMAD4/PPP1CB",7
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","8/43","89/2914",3.33398795610893e-05,0.000756288846885764,0.000437759083433694,"STAT3/MAPK1/MAPK14/CDK5/MAPK3/DUSP7/SRC/IRS1",8
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","8/43","92/2914",4.25259510032881e-05,0.000916434244120858,0.00053045528356733,"MAPK1/AKT1/MAPK3/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1",8
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","7/43","70/2914",5.51853771129671e-05,0.00113261416836614,0.000655585682996151,"STAT3/MAPK1/MAPK14/MAPK3/DUSP7/SRC/IRS1",7
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/43","30/2914",5.98004662544887e-05,0.00117154549798566,0.000678120119727934,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/43","49/2914",6.28474215710828e-05,0.00117770603031029,0.000681685991411745,"SMAD2/AKT1/SMAD3/SIRT1/HDAC1/SMAD4",6
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","9/43","130/2914",8.23368433138445e-05,0.0014328680967432,0.000829380239169954,"MAPK1/MEN1/MAPK14/MAPK3/PAK1/SRC/PPP2R5B/PPP2R5C/PPP1CB",9
"R-HSA-1643685","R-HSA-1643685","Disease","17/43","443/2914",8.31129986509975e-05,0.0014328680967432,0.000829380239169954,"STAT3/MAPK1/SMAD2/CDK5/NR4A1/AKT1/MAPK3/SMAD3/HDAC1/SMAD4/HSP90AB1/AMER1/SRC/PPP2R5B/PPP2R5C/KITLG/IRS1",17
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","11/43","202/2914",0.000108425751026292,0.00179736533432046,0.00104036044507009,"MAPK1/DUSP2/MAPK3/PAK1/DUSP7/SRC/DUSP10/PPP2R5B/PPP2R5C/KITLG/IRS1",11
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","10/43","171/2914",0.000131500439851938,0.00195029662974361,0.00112888094089446,"MAPK1/DUSP2/MAPK3/DUSP7/SRC/DUSP10/PPP2R5B/PPP2R5C/KITLG/IRS1",10
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/43","19/2914",0.000135751505550599,0.00195029662974361,0.00112888094089446,"AKT1/SRC/PPP2R5B/PPP2R5C",4
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/43","19/2914",0.000135751505550599,0.00195029662974361,0.00112888094089446,"MAPK1/MAPK3/ZNF521/SRC",4
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","4/43","19/2914",0.000135751505550599,0.00195029662974361,0.00112888094089446,"SMAD2/SMAD3/HDAC1/SMAD4",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","12/43","249/2914",0.000161335968432489,0.00219254739216863,0.00126910179983872,"MAPK1/AKT1/CSNK2A1/MAPK3/CSNK1D/HDAC1/HSP90AB1/PTK6/SRC/PPP2R5B/PPP2R5C/PPP1CB",12
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","4/43","20/2914",0.000167874858333097,0.00219254739216863,0.00126910179983872,"SMAD2/SMAD3/HDAC1/SMAD4",4
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/43","20/2914",0.000167874858333097,0.00219254739216863,0.00126910179983872,"MAPK1/CSNK2A1/MAPK3/PAK1",4
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","10/43","177/2914",0.000175666659841741,0.00222683324681737,0.00128894731834343,"MAPK1/DUSP2/MAPK3/DUSP7/SRC/DUSP10/PPP2R5B/PPP2R5C/KITLG/IRS1",10
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","6/43","59/2914",0.000181418268468831,0.00223403639171618,0.00129311668051468,"MAPK1/AKT1/CSNK2A1/MAPK3/ATF2/HDAC1",6
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/43","21/2914",0.000205157744708165,0.00241697054437284,0.00139900358777962,"MAPK1/MAPK14/MAPK3/DUSP7",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","7/43","86/2914",0.000207489350677019,0.00241697054437284,0.00139900358777962,"MEN1/SMAD2/SP1/SMAD3/HDAC1/SMAD4/PPP1CB",7
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","6/43","62/2914",0.000239486919349338,0.0027162858484096,0.0015722548444818,"MAPK1/AKT1/MAPK3/ZNF521/SMAD4/SRC",6
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","10/43","188/2914",0.00028956994492575,0.00320011913494867,0.00185230976916067,"MAPK1/DUSP2/MAPK3/DUSP7/SRC/DUSP10/PPP2R5B/PPP2R5C/KITLG/IRS1",10
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/43","24/2914",0.000352691225068723,0.00370755897572243,0.00214602876357605,"MAPK1/MAPK14/MAPK3/DUSP7",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/43","24/2914",0.000352691225068723,0.00370755897572243,0.00214602876357605,"STAT3/MAPK1/MAPK3/IRS1",4
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/43","11/2914",0.000455015707407357,0.00466932785458502,0.00270272487858505,"STAT3/SMAD2/SMAD4",3
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","5/43","46/2914",0.000482910322576258,0.00484033369838063,0.002801707379451,"NR4A1/NR0B2/NR2C2AP/RARG/RARB",5
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/43","27/2914",0.000564041881023628,0.00552504660729963,0.00319803650245454,"STAT3/CEBPB/MYB/FLI1",4
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/43","12/2914",0.000600456688925312,0.00562601810710455,0.00325648135641416,"SMAD2/SMAD3/SMAD4",3
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/43","12/2914",0.000600456688925312,0.00562601810710455,0.00325648135641416,"MAPK1/MAPK3/DUSP7",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","5/43","49/2914",0.000650123521901097,0.00584564610299111,0.00338360758678445,"SP1/MYB/ATF2/HDAC1/HSP90AB1",5
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","4/43","28/2914",0.000651023231887641,0.00584564610299111,0.00338360758678445,"SMAD2/SMAD3/SMAD4/PPP1CB",4
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","3/43","13/2914",0.000772580226804451,0.00616633477319849,0.00356923028757612,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/43","108/2914",0.000845240296161689,0.00645302579239715,0.00373517428940805,"MEN1/AKT1/CSNK2A1/HDAC1/AMER1/PPP2R5B/PPP2R5C",7
"R-HSA-373760","R-HSA-373760","L1CAM interactions","5/43","53/2914",0.000936547601383843,0.00645302579239715,0.00373517428940805,"MAPK1/CSNK2A1/MAPK3/PAK1/SRC",5
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","5/43","53/2914",0.000936547601383843,0.00645302579239715,0.00373517428940805,"AKT1/PAK1/SRC/PPP2R5B/PPP2R5C",5
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"MAPK1/MAPK3/SRC",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/43","14/2914",0.000973194145025093,0.00645302579239715,0.00373517428940805,"SMAD2/SMAD3/SMAD4",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","13/43","347/2914",0.000994829781647973,0.00649653993773146,0.00376036137560717,"STAT3/MAPK1/MAPK14/CDK5/AKT1/MAPK3/PAK1/DUSP7/PTK6/GRB10/SRC/KITLG/IRS1",13
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/43","32/2914",0.00109535591198908,0.00704624474727306,0.00407854440127907,"MAPK1/MAPK3/ATF2/HDAC1",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/43","15/2914",0.00120401544633413,0.00752073416478276,0.00435319085859938,"SMAD2/SMAD3/SMAD4",3
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","3/43","15/2914",0.00120401544633413,0.00752073416478276,0.00435319085859938,"MAPK14/PPP2R5B/PPP2R5C",3
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","4/43","33/2914",0.00123314569635102,0.00759265421610415,0.0043948200005292,"MAPK1/MAPK14/MAPK3/SRC",4
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/43","16/2914",0.00146667290133553,0.00877966695105021,0.00508189294760996,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/43","16/2914",0.00146667290133553,0.00877966695105021,0.00508189294760996,"MAPK1/MAPK14/MAPK3",3
"R-HSA-450294","R-HSA-450294","MAP kinase activation","5/43","60/2914",0.00165125433108238,0.00974918653008915,0.00564307536361248,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/43","37/2914",0.00190678398067584,0.011000383310214,0.00636729965690737,"HDAC1/AMER1/PPP2R5B/PPP2R5C",4
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","5/43","62/2914",0.00191421983356392,0.011000383310214,0.00636729965690737,"MAPK1/MAPK3/PAK1/HSP90AB1/SRC",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","5/43","64/2914",0.00220674985810119,0.0125145945900212,0.00724376338462581,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","6/43","95/2914",0.00235502193735365,0.0131820059090834,0.00763007791049645,"MAPK14/CDK5/AKT1/CSNK2A1/HDAC1/PPP2R5C",6
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","4/43","41/2914",0.0028011834065717,0.0154783339516975,0.00895925057162609,"STAT3/GRB10/SRC/KITLG",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/43","99/2914",0.00290556013266356,0.015851853382,0.00917545305051652,"STAT3/MAPK1/MAPK14/CEBPB/SP1/MAPK3",6
"R-HSA-422475","R-HSA-422475","Axon guidance","10/43","254/2914",0.00305658966432619,0.0164673768165574,0.00953173355849089,"MAPK1/MAPK14/CDK5/CSNK2A1/MAPK3/PAK1/HSP90AB1/GRB10/SRC/EPHA4",10
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","4/43","43/2914",0.003341311696935,0.0177790782886294,0.0102909794954333,"MAPK1/MAPK3/PAK1/HSP90AB1",4
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","3/43","22/2914",0.00379189670317225,0.0199305790130151,0.0115363224473918,"SMAD2/SMAD3/PPP1CB",3
"R-HSA-68886","R-HSA-68886","M Phase","6/43","105/2914",0.00390646532734019,0.0202603300021649,0.0117271906472416,"MAPK1/CSNK2A1/MAPK3/CSNK1D/PPP2R5B/PPP2R5C",6
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/43","45/2914",0.00394864900274212,0.0202603300021649,0.0117271906472416,"STAT3/MAPK1/CEBPB/MAPK3",4
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/43","23/2914",0.00431611865592431,0.0218852604788633,0.0126677414421556,"MAPK1/SP1/MAPK3",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/43","24/2914",0.00488232257461797,0.024468384065818,0.0141629186069089,"MAPK1/AKT1/MAPK3",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","9/43","228/2914",0.00501323313638783,0.0248356722044041,0.0143755142567927,"MAPK1/MEN1/MAPK14/MAPK3/PAK1/SRC/PPP2R5B/PPP2R5C/PPP1CB",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","8/43","187/2914",0.0051308009437847,0.0248416919326732,0.0143789986275334,"STAT3/MAPK1/MAPK14/CEBPB/SP1/MAPK3/SIRT1/HSP90AB1",8
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/43","78/2914",0.00524499760063402,0.0248416919326732,0.0143789986275334,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/43","78/2914",0.00524499760063402,0.0248416919326732,0.0143789986275334,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/43","78/2914",0.00524499760063402,0.0248416919326732,0.0143789986275334,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/43","49/2914",0.00538012219891804,0.0249138434579661,0.0144207617524434,"STAT3/MAPK1/AKT1/MAPK3",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/43","49/2914",0.00538012219891804,0.0249138434579661,0.0144207617524434,"MAPK1/MAPK3/SIRT1/HSP90AB1",4
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","8/43","189/2914",0.00547350945639763,0.0249138434579661,0.0144207617524434,"STAT3/MAPK1/MAPK14/CEBPB/SP1/MAPK3/SIRT1/HSP90AB1",8
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","3/43","25/2914",0.00549145041416885,0.0249138434579661,0.0144207617524434,"MAPK1/MAPK3/SRC",3
"R-HSA-400253","R-HSA-400253","Circadian Clock","4/43","52/2914",0.00665772190226522,0.0292803891824113,0.0169482286878288,"SIRT1/ATF2/CSNK1D/PPP1CB",4
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","4/43","52/2914",0.00665772190226522,0.0292803891824113,0.0169482286878288,"MAPK1/MAPK3/GRB10/IRS1",4
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","4/43","52/2914",0.00665772190226522,0.0292803891824113,0.0169482286878288,"MAPK1/MAPK3/GRB10/IRS1",4
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/43","83/2914",0.00683107401546681,0.0294886789912219,0.0170687920891918,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/43","27/2914",0.00684192087963385,0.0294886789912219,0.0170687920891918,"MAPK1/MAPK3/SRC",3
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/43","84/2914",0.00718473966637048,0.0303590470216243,0.0175725830849309,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/43","84/2914",0.00718473966637048,0.0303590470216243,0.0175725830849309,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/43","28/2914",0.00758482859736339,0.031738457528773,0.0183710207212583,"MAPK1/MAPK3/SRC",3
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/43","86/2914",0.00793039278035653,0.0322452763050346,0.01866438022785,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/43","86/2914",0.00793039278035653,0.0322452763050346,0.01866438022785,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/43","86/2914",0.00793039278035653,0.0322452763050346,0.01866438022785,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/43","87/2914",0.00832284008640564,0.032810048562264,0.0189912846727478,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/43","87/2914",0.00832284008640564,0.032810048562264,0.0189912846727478,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/43","87/2914",0.00832284008640564,0.032810048562264,0.0189912846727478,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-5673000","R-HSA-5673000","RAF activation","3/43","29/2914",0.00837379429663351,0.032810048562264,0.0189912846727478,"SRC/PPP2R5B/PPP2R5C",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/43","56/2914",0.00865509254754582,0.0335748833025461,0.019433990335092,"CSNK2A1/CSNK1D/PPP2R5B/PPP2R5C",4
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/43","10/2914",0.00888059558350408,0.0335748833025461,0.019433990335092,"MAPK1/MAPK3",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/43","10/2914",0.00888059558350408,0.0335748833025461,0.019433990335092,"CSNK2A1/SRC",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/43","10/2914",0.00888059558350408,0.0335748833025461,0.019433990335092,"MAPK1/MAPK3",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/43","30/2914",0.00920945274734639,0.0339254199496264,0.0196368897986603,"MAPK1/MAPK3/PAK1",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","3/43","30/2914",0.00920945274734639,0.0339254199496264,0.0196368897986603,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","3/43","30/2914",0.00920945274734639,0.0339254199496264,0.0196368897986603,"MAPK1/MAPK3/SRC",3
"R-HSA-109582","R-HSA-109582","Hemostasis","10/43","298/2914",0.00957823731819671,0.0344131255860551,0.0199191861372452,"MAPK1/MAPK14/CDK5/AKT1/MAPK3/MYB/HDAC1/SRC/PPP2R5B/PPP2R5C",10
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/43","90/2914",0.00958138067361163,0.0344131255860551,0.0199191861372452,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/43","90/2914",0.00958138067361163,0.0344131255860551,0.0199191861372452,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/43","31/2914",0.0100923829412094,0.0353643662411483,0.0204697882504632,"MEN1/AKT1/HDAC1",3
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","3/43","31/2914",0.0100923829412094,0.0353643662411483,0.0204697882504632,"AKT1/PAK1/SRC",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/43","31/2914",0.0100923829412094,0.0353643662411483,0.0204697882504632,"AMER1/PPP2R5B/PPP2R5C",3
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","2/43","11/2914",0.0107529466670811,0.0368291500483715,0.0213176421088388,"STAT3/IRS1",2
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","2/43","11/2914",0.0107529466670811,0.0368291500483715,0.0213176421088388,"PAK1/PPP1CB",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/43","32/2914",0.0110231098752666,0.0368291500483715,0.0213176421088388,"MAPK1/MAPK3/SIRT1",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/43","32/2914",0.0110231098752666,0.0368291500483715,0.0213176421088388,"MAPK1/MAPK3/SRC",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/43","32/2914",0.0110231098752666,0.0368291500483715,0.0213176421088388,"MAPK1/MAPK3/SRC",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/43","32/2914",0.0110231098752666,0.0368291500483715,0.0213176421088388,"MAPK1/MAPK3/SRC",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/43","172/2914",0.0116811626290824,0.0387275468702655,0.0224164821303039,"MEN1/AKT1/CSNK2A1/HDAC1/AMER1/PPP2R5B/PPP2R5C",7
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/43","12/2914",0.0127834446627123,0.0409915429190963,0.0237269402169394,"MAPK1/MAPK3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/43","12/2914",0.0127834446627123,0.0409915429190963,0.0237269402169394,"MAPK1/MAPK3",2
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","2/43","12/2914",0.0127834446627123,0.0409915429190963,0.0237269402169394,"PAK1/HSP90AB1",2
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","2/43","12/2914",0.0127834446627123,0.0409915429190963,0.0237269402169394,"RARG/RARB",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/43","97/2914",0.0130196871624603,0.0409915429190963,0.0237269402169394,"NR4A1/AKT1/SRC/KITLG/IRS1",5
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/43","63/2914",0.0130279119001626,0.0409915429190963,0.0237269402169394,"MAPK1/AKT1/MAPK3/SRC",4
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/43","34/2914",0.0130297943849564,0.0409915429190963,0.0237269402169394,"MAPK1/MAPK3/SRC",3
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","3/43","35/2914",0.0141065474464151,0.0440574054304703,0.0255015388619403,"MAPK14/PAK1/SRC",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/43","13/2914",0.0149672381965137,0.04607771187641,0.0266709432524342,"MAPK1/MAPK3",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/43","13/2914",0.0149672381965137,0.04607771187641,0.0266709432524342,"MAPK14/SRC",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/43","37/2914",0.0164085068676672,0.0501564997160608,0.0290318486572388,"MAPK1/MAPK3/SRC",3
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/43","14/2914",0.0172995788717618,0.0525078767164038,0.0303928850452746,"AKT1/HDAC1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","3/43","38/2914",0.0176342297286949,0.0527802292574132,0.0305505295738355,"CDK5/PAK1/HSP90AB1",3
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/43","38/2914",0.0176342297286949,0.0527802292574132,0.0305505295738355,"MAPK1/MAPK3/SRC",3
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","2/43","15/2914",0.0197758193987507,0.0583793024716545,0.0337914145458105,"SRC/KITLG",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/43","15/2914",0.0197758193987507,0.0583793024716545,0.0337914145458105,"STAT3/SMAD3",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/43","110/2914",0.0214692764820554,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","7/43","194/2914",0.021574373074376,0.0624528691330463,0.0361492978007864,"MAPK14/CDK5/AKT1/CSNK2A1/ATF2/HDAC1/PPP2R5C",7
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/43","41/2914",0.0216125740778192,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3/SRC",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/43","16/2914",0.0223914117555243,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3",2
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","2/43","16/2914",0.0223914117555243,0.0624528691330463,0.0361492978007864,"PAK1/SRC",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/43","16/2914",0.0223914117555243,0.0624528691330463,0.0361492978007864,"CSNK2A1/SRC",2
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","2/43","16/2914",0.0223914117555243,0.0624528691330463,0.0361492978007864,"PAK1/PPP1CB",2
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","2/43","16/2914",0.0223914117555243,0.0624528691330463,0.0361492978007864,"SRC/IRS1",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","3/43","42/2914",0.0230394575223999,0.0624528691330463,0.0361492978007864,"MAPK14/PPP2R5B/PPP2R5C",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/43","42/2914",0.0230394575223999,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3/SRC",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/43","42/2914",0.0230394575223999,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3/SRC",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/43","42/2914",0.0230394575223999,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3/SRC",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/43","42/2914",0.0230394575223999,0.0624528691330463,0.0361492978007864,"MAPK1/MAPK3/SRC",3
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/43","17/2914",0.025141905379008,0.0673053491823132,0.0389580357948669,"MAPK14/SRC",2
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","2/43","17/2914",0.025141905379008,0.0673053491823132,0.0389580357948669,"SIRT1/HDAC1",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","4/43","77/2914",0.0255072942890198,0.0678619990035033,0.039280238768666,"AKT1/HDAC1/PTK6/SRC",4
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","3/43","44/2914",0.0260446584991773,0.0684466330069843,0.0396186396938705,"AKT1/PTK6/SRC",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/43","44/2914",0.0260446584991773,0.0684466330069843,0.0396186396938705,"MAPK1/MAPK14/MAPK3",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/43","18/2914",0.0280229453860708,0.0731993300690699,0.0423696207751119,"MAPK1/MAPK3",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/43","80/2914",0.0288776451012997,0.0749775002328926,0.0433988705707548,"SMAD2/SMAD3/SMAD4/MUL1",4
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/43","46/2914",0.029251611789818,0.0754936807270152,0.0436976488760596,"MAPK1/MAPK3/SRC",3
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/43","47/2914",0.0309305614810185,0.0779594853702864,0.0451249188735081,"MAPK1/MAPK3/SRC",3
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/43","47/2914",0.0309305614810185,0.0779594853702864,0.0451249188735081,"SRC/PPP2R5B/PPP2R5C",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/43","47/2914",0.0309305614810185,0.0779594853702864,0.0451249188735081,"STAT3/AKT1/PTK6",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/43","47/2914",0.0309305614810185,0.0779594853702864,0.0451249188735081,"STAT3/AKT1/PTK6",3
"R-HSA-167044","R-HSA-167044","Signalling to RAS","2/43","20/2914",0.034159712950334,0.0838593686533552,0.0485399203097941,"MAPK14/SRC",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/43","20/2914",0.034159712950334,0.0838593686533552,0.0485399203097941,"MAPK1/SRC",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/43","20/2914",0.034159712950334,0.0838593686533552,0.0485399203097941,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/43","20/2914",0.034159712950334,0.0838593686533552,0.0485399203097941,"MAPK3/HDAC1",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/43","49/2914",0.0344387662451134,0.0838593686533552,0.0485399203097941,"MAPK1/MAPK3/SRC",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/43","49/2914",0.0344387662451134,0.0838593686533552,0.0485399203097941,"MAPK1/MAPK3/SRC",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","4/43","85/2914",0.0350642510044355,0.0849027650725377,0.0491438645065123,"MAPK14/AKT1/PAK1/SRC",4
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/43","50/2914",0.0362676772271899,0.0871286944835415,0.0504322886618619,"MAPK1/MAPK3/SRC",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/43","86/2914",0.0363878538446345,0.0871286944835415,0.0504322886618619,"CSNK2A1/MYB/HDAC1/SRC",4
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/43","127/2914",0.0370906538989967,0.0881010951689187,0.0509951387349707,"MAPK1/MAPK14/MAPK3/ATF2/DUSP7",5
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","2/43","21/2914",0.0374071935403994,0.0881010951689187,0.0509951387349707,"SRC/EPHA4",2
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","2/43","21/2914",0.0374071935403994,0.0881010951689187,0.0509951387349707,"AKT1/PAK1",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/43","22/2914",0.0407687232241221,0.0944694608042829,0.0546813095875322,"STAT3/IRS1",2
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/43","22/2914",0.0407687232241221,0.0944694608042829,0.0546813095875322,"MEN1/HDAC1",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/43","22/2914",0.0407687232241221,0.0944694608042829,0.0546813095875322,"MAPK1/MAPK3",2
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","3/43","53/2914",0.042051007783383,0.0969197024312196,0.0560995713181074,"SMAD3/SMAD4/SRC",3
"R-HSA-392518","R-HSA-392518","Signal amplification","2/43","23/2914",0.0442403998496647,0.101423469868114,0.0587064656459717,"MAPK14/SRC",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","4/43","92/2914",0.044938411511514,0.102478599796098,0.0593172014938948,"MAPK14/AKT1/PAK1/SRC",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/43","55/2914",0.0461510223491965,0.104689950697388,0.0605971872396652,"MAPK1/MAPK3/SRC",3
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/43","24/2914",0.047818406874669,0.107342361265533,0.0621324694588627,"PAK1/PPP1CB",2
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","2/43","24/2914",0.047818406874669,0.107342361265533,0.0621324694588627,"NR4A1/AKT1",2
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/43","56/2914",0.0482734334700446,0.107802330702535,0.0623987113847864,"MAPK14/CDK5/CSNK2A1",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","9/43","332/2914",0.0490733721542751,0.109023831950993,0.0631057471544395,"STAT3/MAPK1/MAPK14/AKT1/MAPK3/SMAD3/ATF2/DUSP7/IRS1",9
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"AKT1/SRC",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"AKT1/PAK1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"MAPK1/MAPK3",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"AKT1/CSNK2A1",2
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"CDK5/SRC",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/43","25/2914",0.0514990117842777,0.110980370395118,0.0642382410151253,"AKT1/SRC",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","3/43","60/2914",0.057237256859616,0.122732625405445,0.0710407429993663,"AKT1/HDAC1/PTK6",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/43","27/2914",0.0591534960280533,0.125566923257095,0.0726813061715263,"RARG/RARB",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/43","27/2914",0.0591534960280533,0.125566923257095,0.0726813061715263,"RARG/RARB",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/43","61/2914",0.0595947397770882,0.125566923257095,0.0726813061715263,"CSNK2A1/HSP90AB1/SRC",3
"R-HSA-109581","R-HSA-109581","Apoptosis","4/43","101/2914",0.0597244066536065,0.125566923257095,0.0726813061715263,"STAT3/MAPK1/AKT1/MAPK3",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/43","62/2914",0.061997964252412,0.129714187343639,0.0750818473572899,"CDK5/MYB/HDAC1",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","4/43","103/2914",0.0633275249262625,0.131855861078353,0.076321502199462,"STAT3/MAPK1/AKT1/MAPK3",4
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"PPP2R5B/PPP2R5C",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"PPP2R5B/PPP2R5C",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"STAT3/SRC",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"CEBPB/PPP2R5B",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"AKT1/PPP2R5C",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/43","29/2914",0.067175614548016,0.135928121456314,0.0786786293445999,"AKT1/PPP2R5C",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/43","30/2914",0.0713160546766352,0.143631867129111,0.0831377518856987,"STAT3/CSNK2A1",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/43","66/2914",0.0720587863982397,0.143791753803311,0.0832302983304061,"CSNK1D/HSP90AB1/PPP1CB",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","5/43","153/2914",0.0720626886810099,0.143791753803311,0.0832302983304061,"MAPK1/MAPK14/AKT1/MAPK3/SRC",5
"R-HSA-391251","R-HSA-391251","Protein folding","2/43","31/2914",0.0755383768652853,0.149344222151092,0.0864442072287427,"STAT3/CSNK2A1",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/43","31/2914",0.0755383768652853,0.149344222151092,0.0864442072287427,"MAPK14/AKT1",2
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","3/43","68/2914",0.0773509126660313,0.151537469813907,0.0877137143629158,"PAK1/SRC/EPHA4",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/43","68/2914",0.0773509126660313,0.151537469813907,0.0877137143629158,"CSNK1D/HSP90AB1/PPP1CB",3
"R-HSA-8853659","R-HSA-8853659","RET signaling","2/43","32/2914",0.0798393946646199,0.155704882807471,0.0901259182448912,"GRB10/SRC",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","2/43","33/2914",0.0842159939143916,0.1627672348749,0.094213785969841,"MAPK1/MAPK3",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/43","33/2914",0.0842159939143916,0.1627672348749,0.094213785969841,"AKT1/SRC",2
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","3/43","72/2914",0.0884371186453903,0.169091467375783,0.0978744114496534,"SRC/KITLG/IRS1",3
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/43","34/2914",0.0886651313849813,0.169091467375783,0.0978744114496534,"PPP2R5B/PPP2R5C",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/43","34/2914",0.0886651313849813,0.169091467375783,0.0978744114496534,"PAK1/SRC",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/43","37/2914",0.102418376896367,0.193606668606728,0.11206442901403,"SIRT1/HDAC1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/43","37/2914",0.102418376896367,0.193606668606728,0.11206442901403,"CSNK1D/PPP1CB",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/43","77/2914",0.103188558755169,0.19421078088855,0.112414104458631,"MAPK1/MAPK3/SRC",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/43","38/2914",0.107128607294571,0.200749694538956,0.116198992809214,"MAPK14/ATF2",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","4/43","124/2914",0.107841159363478,0.201210128509347,0.116465503618794,"SMAD2/SMAD3/SMAD4/MUL1",4
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/43","39/2914",0.111897177764053,0.207877946622011,0.120325005127407,"AKT1/PTK6",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/43","80/2914",0.112487064285589,0.208076930073344,0.120440181774044,"MAPK14/ATF2/CSNK1D",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/43","40/2914",0.116721443390688,0.211373706308347,0.122348439113636,"CEBPB/NR2F2",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/43","40/2914",0.116721443390688,0.211373706308347,0.122348439113636,"PTK6/SRC",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/43","40/2914",0.116721443390688,0.211373706308347,0.122348439113636,"PTK6/SRC",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/43","40/2914",0.116721443390688,0.211373706308347,0.122348439113636,"AKT1/PTK6",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/43","40/2914",0.116721443390688,0.211373706308347,0.122348439113636,"AKT1/SMAD3",2
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","2/43","42/2914",0.126526789493257,0.227221026131641,0.131521268025886,"SRC/EPHA4",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/43","42/2914",0.126526789493257,0.227221026131641,0.131521268025886,"PPP2R5B/PPP2R5C",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/43","87/2914",0.135378615797713,0.237350865079522,0.13738467462168,"MAPK1/MAPK3/PAK1",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"MAPK3",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"HDAC1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"SRC",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"HSP90AB1",1
"R-HSA-3371511","R-HSA-3371511","HSF1 activation","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"HSP90AB1",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"PPP2R5B",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"AKT1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/43","10/2914",0.138340299076546,0.237350865079522,0.13738467462168,"SIRT1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/43","88/2914",0.138775911833039,0.237350865079522,0.13738467462168,"MAPK1/MAPK3/SRC",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"STAT3",1
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"AKT1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"HDAC1",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"AKT1",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"SRC",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"HSP90AB1",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"CEBPB",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"SRC",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"STAT3",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/43","11/2914",0.151099034317492,0.248563678590989,0.143874934243655,"AKT1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/43","48/2914",0.157023140705793,0.255591087233347,0.147942575831733,"MAPK14/HSP90AB1",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/43","49/2914",0.162239497065822,0.255591087233347,0.147942575831733,"STAT3/SRC",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"CSNK2A1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"STAT3",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"CSNK1D",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"PPP2R5B",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"PAK1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"CSNK1D",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"CSNK1D",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"HSP90AB1",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"CSNK1D",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"HDAC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/43","12/2914",0.163673178831563,0.255591087233347,0.147942575831733,"HDAC1",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"AKT1",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"SRC",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"SRC",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"PAK1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"MEN1",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"SP1",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"PTK6",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"AKT1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/43","13/2914",0.176065340551151,0.266260216763319,0.154118137435356,"PAK1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/43","53/2914",0.183409622934318,0.276397019177241,0.159985574661146,"CSNK2A1/SRC",2
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"HSP90AB1",1
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"SP1",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"CEBPB",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"PAK1",1
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"PTK6",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"STAT3",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/43","14/2914",0.188278091449565,0.276955144760282,0.160308631843172,"SRC",1
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","3/43","104/2914",0.196737624236544,0.283403160812947,0.16404090636871,"AKT1/SMAD3/HDAC1",3
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/43","56/2914",0.199553223063001,0.283403160812947,0.16404090636871,"PPP2R5B/PPP2R5C",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"AKT1",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"HSP90AB1",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"HDAC1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"HDAC1",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"HDAC1",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"CDK5",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"SRC",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/43","15/2914",0.200313968024624,0.283403160812947,0.16404090636871,"AKT1",1
"R-HSA-112316","R-HSA-112316","Neuronal System","3/43","105/2914",0.200552120760902,0.283403160812947,0.16404090636871,"MAPK1/MAPK3/SRC",3
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/43","16/2914",0.212175471775896,0.294992349469069,0.170749021429159,"HDAC1",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/43","16/2914",0.212175471775896,0.294992349469069,0.170749021429159,"AKT1",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/43","16/2914",0.212175471775896,0.294992349469069,0.170749021429159,"HSP90AB1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/43","16/2914",0.212175471775896,0.294992349469069,0.170749021429159,"HSP90AB1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/43","16/2914",0.212175471775896,0.294992349469069,0.170749021429159,"SRC",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/43","59/2914",0.215870940719382,0.298371820199285,0.172705144430896,"MAPK1/CDK5",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","3/43","109/2914",0.215990737592058,0.298371820199285,0.172705144430896,"MAPK14/AKT1/CSNK1D",3
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/43","60/2914",0.221341067749029,0.304785943130451,0.176417800761795,"PPP2R5B/PPP2R5C",2
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/43","17/2914",0.223865069675702,0.306304269937231,0.177296646660456,"SRC",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/43","17/2914",0.223865069675702,0.306304269937231,0.177296646660456,"SMAD3",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/43","61/2914",0.226823994120959,0.309370700842194,0.17907157430602,"PPP2R5B/PPP2R5C",2
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/43","62/2914",0.232318195116577,0.315864801562286,0.182830523800859,"STAT3/SRC",2
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/43","18/2914",0.235385194633915,0.318028272373723,0.184082795341488,"PAK1",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/43","18/2914",0.235385194633915,0.318028272373723,0.184082795341488,"CSNK2A1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","2/43","64/2914",0.243334522244191,0.326209153396722,0.188818095872569,"PAK1/SRC",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"HDAC1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"HSP90AB1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"SRC",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"PAK1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/43","19/2914",0.246738245956686,0.326209153396722,0.188818095872569,"HDAC1",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/43","119/2914",0.255635057045569,0.335850030826051,0.194398479193489,"SP1/CSNK2A1/PPP1CB",3
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/43","20/2914",0.257926589799125,0.335850030826051,0.194398479193489,"SP1",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/43","20/2914",0.257926589799125,0.335850030826051,0.194398479193489,"CSNK1D",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/43","20/2914",0.257926589799125,0.335850030826051,0.194398479193489,"HSP90AB1",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/43","20/2914",0.257926589799125,0.335850030826051,0.194398479193489,"HDAC1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/43","21/2914",0.268952559612062,0.348103763341737,0.201491249021838,"AKT1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/43","21/2914",0.268952559612062,0.348103763341737,0.201491249021838,"MAPK14",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/43","22/2914",0.279818456582916,0.356977196666601,0.20662741631453,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/43","22/2914",0.279818456582916,0.356977196666601,0.20662741631453,"PTK6",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/43","22/2914",0.279818456582916,0.356977196666601,0.20662741631453,"MAPK14",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/43","22/2914",0.279818456582916,0.356977196666601,0.20662741631453,"HDAC1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/43","125/2914",0.279949634508842,0.356977196666601,0.20662741631453,"MAPK1/MAPK14/HSP90AB1",3
"R-HSA-69242","R-HSA-69242","S Phase","2/43","71/2914",0.282041051082133,0.358583165240116,0.20755699148103,"AKT1/PTK6",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/43","72/2914",0.287572592008898,0.363666465548883,0.210499334070303,"PAK1/SRC",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/43","23/2914",0.290526550070791,0.363666465548883,0.210499334070303,"SMAD4",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/43","23/2914",0.290526550070791,0.363666465548883,0.210499334070303,"HDAC1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/43","23/2914",0.290526550070791,0.363666465548883,0.210499334070303,"STAT3",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/43","23/2914",0.290526550070791,0.363666465548883,0.210499334070303,"CSNK1D",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","8/43","428/2914",0.291101927179501,0.363666465548883,0.210499334070303,"MAPK1/MAPK14/MAPK3/PAK1/ATF2/DUSP7/HSP90AB1/SRC",8
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/43","24/2914",0.30107907803584,0.371819721012742,0.215218644230113,"STAT3",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/43","24/2914",0.30107907803584,0.371819721012742,0.215218644230113,"AKT1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/43","24/2914",0.30107907803584,0.371819721012742,0.215218644230113,"STAT3",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/43","24/2914",0.30107907803584,0.371819721012742,0.215218644230113,"AKT1",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/43","25/2914",0.311478247462988,0.381383876865193,0.220754619164857,"CSNK1D",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/43","25/2914",0.311478247462988,0.381383876865193,0.220754619164857,"CSNK1D",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/43","25/2914",0.311478247462988,0.381383876865193,0.220754619164857,"AKT1",1
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/43","26/2914",0.321726234780084,0.388414585966993,0.224824171142208,"MAPK1",1
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/43","26/2914",0.321726234780084,0.388414585966993,0.224824171142208,"AKT1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/43","26/2914",0.321726234780084,0.388414585966993,0.224824171142208,"HDAC1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/43","26/2914",0.321726234780084,0.388414585966993,0.224824171142208,"CSNK1D",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/43","26/2914",0.321726234780084,0.388414585966993,0.224824171142208,"CSNK1D",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"SRC",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"AKT1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"CSNK1D",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"CSNK1D",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"SRC",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/43","27/2914",0.331825186270547,0.393985276260622,0.228048627362968,"MYB",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/43","28/2914",0.341777218480581,0.403387642375183,0.233490954311682,"CSNK1D",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/43","28/2914",0.341777218480581,0.403387642375183,0.233490954311682,"SP1",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/43","82/2914",0.342551919047139,0.403387642375183,0.233490954311682,"STAT3/SMAD3",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/43","29/2914",0.351584418621029,0.412896142849219,0.238994714507913,"AKT1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/43","144/2914",0.358053139192927,0.418562084843276,0.242274304818309,"AKT1/CSNK1D/SRC",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","7/43","393/2914",0.358351297696448,0.418562084843276,0.242274304818309,"MEN1/SMAD2/SMAD3/CSNK1D/HDAC1/SMAD4/MUL1",7
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/43","30/2914",0.361248844963939,0.420806086971508,0.243573189918787,"CSNK2A1",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/43","31/2914",0.370772527233895,0.429577847413464,0.248650506379267,"AKT1",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/43","31/2914",0.370772527233895,0.429577847413464,0.248650506379267,"STAT3",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/43","32/2914",0.380157466994194,0.438095904477266,0.253580972917602,"ATF2",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/43","32/2914",0.380157466994194,0.438095904477266,0.253580972917602,"STAT3",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/43","33/2914",0.389405638027937,0.447556879973443,0.25905722445648,"MAPK14",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"MAPK3",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"ATF2",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"CSNK1D",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"PAK1",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/43","34/2914",0.398518986714087,0.449637914329245,0.260261779694788,"ATF2",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","2/43","94/2914",0.406825618122111,0.456187676269562,0.264052947309528,"STAT3/AKT1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/43","35/2914",0.407499432398565,0.456187676269562,0.264052947309528,"MAPK3",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/43","35/2914",0.407499432398565,0.456187676269562,0.264052947309528,"AKT1",1
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/43","36/2914",0.416348867760448,0.464886948198842,0.269088305588291,"SRC",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/43","160/2914",0.423344046516137,0.471476186171719,0.272902322927579,"AKT1/CSNK1D/SRC",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/43","289/2914",0.425538844025661,0.472699076739845,0.273610162870542,"SP1/AKT1/CSNK2A1/HSP90AB1/PPP1CB",5
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/43","296/2914",0.446767864133878,0.495005011418256,0.286521401162844,"AKT1/PAK1/SRC/PPP2R5B/PPP2R5C",5
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/43","40/2914",0.450473446327423,0.497830911197742,0.288157103318756,"HDAC1",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/43","41/2914",0.458695311953004,0.504330814927921,0.291919411742379,"STAT3",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/43","41/2914",0.458695311953004,0.504330814927921,0.291919411742379,"HDAC1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/43","42/2914",0.46679698323251,0.509340505754967,0.294819147304743,"IRS1",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/43","42/2914",0.46679698323251,0.509340505754967,0.294819147304743,"CSNK1D",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/43","42/2914",0.46679698323251,0.509340505754967,0.294819147304743,"STAT3",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/43","44/2914",0.482646582312557,0.521652723188465,0.301945769680465,"SRC",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/43","44/2914",0.482646582312557,0.521652723188465,0.301945769680465,"SRC",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/43","109/2914",0.482922126571224,0.521652723188465,0.301945769680465,"ATF2/HDAC1",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/43","109/2914",0.482922126571224,0.521652723188465,0.301945769680465,"ATF2/HDAC1",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/43","45/2914",0.490397870452125,0.528403705412164,0.30585340867672,"STAT3",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/43","46/2914",0.498035685569085,0.535295213167769,0.309842387399588,"IRS1",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/43","47/2914",0.505561649837052,0.542032515123804,0.313742107911446,"SP1",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","2/43","114/2914",0.50700219365304,0.542228152517271,0.313855347775292,"PPP2R5B/PPP2R5C",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/43","48/2914",0.512977362797291,0.547260503380279,0.316768199538713,"SP1",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/43","50/2914",0.527484321641682,0.557877483828947,0.322913575937136,"IRS1",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/43","50/2914",0.527484321641682,0.557877483828947,0.322913575937136,"MEN1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"IRS1",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"IRS1",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"HDAC1",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"HDAC1",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"HDAC1",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"HDAC1",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/43","51/2914",0.534578656198039,0.557877483828947,0.322913575937136,"HDAC1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/43","53/2914",0.548456596126293,0.569601910675741,0.329699970277569,"PAK1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/43","53/2914",0.548456596126293,0.569601910675741,0.329699970277569,"SRC",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/43","126/2914",0.561875383387272,0.582135313076717,0.336954620098136,"HSP90AB1/SRC",2
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/43","57/2914",0.575010581334073,0.594315492937615,0.344004815792441,"SRC",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/43","59/2914",0.58770933761563,0.605987379216116,0.350760798325118,"PAK1",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/43","61/2914",0.60003721889474,0.617222055712727,0.357263712795009,"MEN1",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/43","64/2914",0.617856715550663,0.634038677148419,0.366997597958665,"HDAC1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/43","217/2914",0.632066329782342,0.647079781796174,0.37454611866087,"MAPK1/CDK5/SRC",3
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","6/43","436/2914",0.640092458578788,0.653743719543738,0.378403374116171,"MAPK1/CDK5/AKT1/MAPK3/PAK1/SRC",6
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/43","69/2914",0.645847243165342,0.658061848237027,0.380902816051228,"SRC",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/43","73/2914",0.666788485644923,0.677796786115476,0.392325896469332,"SRC",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/43","76/2914",0.681695793766866,0.691319734384751,0.400153320427857,"HDAC1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/43","165/2914",0.71017882008527,0.718514252245895,0.415894194119617,"MAPK1/MAPK3",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","6/43","486/2914",0.7466423286648,0.753636636193276,0.436223916907575,"MAPK1/CDK5/AKT1/MAPK3/PAK1/SRC",6
"R-HSA-913531","R-HSA-913531","Interferon Signaling","1/43","97/2914",0.769270349010016,0.7746624308956,0.448394177853846,"MAPK3",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/43","106/2914",0.799139892993754,0.802865486900485,0.464718818892209,"HDAC1",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","1/43","107/2914",0.80221574221073,0.804081360215871,0.465422597072076,"HDAC1",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","1/43","109/2914",0.80823004506259,0.80823004506259,0.467823960629708,"HDAC1",1
